摘要
目的:探讨前列回春胶囊治疗Ⅲ型慢性前列腺炎的临床疗效。方法:选取慢性非细菌性前列腺炎/慢性骨盆疼痛综合征(CPPS)54例,分为ⅢA型28例,ⅢB型26例。所有病例均给予前列回春胶囊治疗,1.8g/次,3次/d,共治疗3个月。以治疗前后的美国国立卫生研究院慢性前列腺炎症状指数(NIH-CPSI)评分变化、前列腺按摩液(EPS)检查的变化为指标,比较ⅢA型患者与ⅢB型患者对前列回春胶囊治疗的反应性。结果:ⅢA型患者总体有效率为68.0%(17/25),ⅢB型患者总体有效率为38.5%(10/26)。统计分析结果显示,两型患者NIH-CPSI变化比较差异有统计学意义(P<0.05)。结论:前列回春胶囊对不同亚型的慢性前列腺炎具有不同的治疗效果。明确慢性前列腺炎患者的分型对提高治疗效果具有重要意义。
Objective：To investigate the clinical efficacy of the QIANLIEHUICHUN capsule on the treatment of type Ⅲ chronic prostatitis.Methods：54 cases of chronic nonbacterial ptostatitis/chronic pelvic pain syndrome （CPPS） were divided into type Ⅲ A 28 cases, Ⅲ B 26 cases.All cases were given to the QIANLIEHUICHUN capsule treatment（1.8 g/time, 3 times a day, lasted for 3 months）,The changes of the U.S. National Institutes of Health chronic prostatitis symptom index （NIH-CPSI） score were recorded before and after treatment.Also, examination of EPS also used as an index to compare the response of patients with type Ⅲ A and III B chronic prostatitis.Results：The overall effective tale was 68.0% （17/25） in patients with type m A, 38.5% （10/26） in patients with type Ⅲ B.The statistical analysis showed that changes of the NIH-CPSI was much different between the two types of patients with chronic prostatittis （P〈0.05）.Conelttslon; QIANLIEHUICHUN capsule has different therapeutical effect on different type of chronic prostatitis.h is important to identify the type of chronic ptostatitts for improving its therapeutical effect.
出处
《中国医学创新》
CAS
2012年第18期145-146,共2页
Medical Innovation of China
